Direct syntheses of stereoisomers of 3-fluoro GABA and β-fluoroamine analogues of the calcium receptor (CaR) agonists, cinacalcet, tecalcet, fendiline and NPS R-467
Authors (first, second and last of 5)
Collection
Special Issue in Honor of Dr. Nicholas A. Meanwell
Special Issue in honor of Dr. Nicholas A. Meanwell on the occasion of his retirement from Bristol Myers Squibb
Editors
-
John F. Kadow
Alphina Therapeutics Inc., Elm City Bioscience Center, 55 Church Street, New Haven, CT 06510, USA
-
Kap-Sun Yeung
Formerly Bristol Myers Squibb, 100 Binney Street, Cambridge, MA 02142, USA
-
T. G. Murali Dhar
Small Molecule Drug Discovery, Bristol Myers Squibb, Princeton, NJ 08543, USA
Articles (24 in this collection)
-
-
Lead change of a HIF-2α antagonist guided by multiparameter optimization and utilization of an Olp→π*Ar interaction
Authors (first, second and last of 22)
-
-
SARS-CoV-2 3CL-protease inhibitors derived from ML300: investigation of P1 and replacements of the 1,2,3-benzotriazole
Authors (first, second and last of 12)
-
The HBV capsid modulators derived from sulfamoylbenzamides and benzamides: an overview of the progress of patents
Authors (first, second and last of 4)
-
-
Pharmacophore variants of the macrocyclic peptide triazole inactivator of HIV-1 Env
Authors (first, second and last of 8)
-
-
A guide for the synthesis of key nucleoside scaffolds in drug discovery
Authors (first, second and last of 4)
-
The rise of targeting chimeras (TACs): next-generation medicines that preempt cellular events
Authors (first, second and last of 10)
-
-
-
-
A versatile strategy for the synthesis of various lumazine peptides
Authors (first, second and last of 4)
-
-
Discovery and exploration of monosaccharide linked dimers of galectin-3 inhibitors to target fibrosis
Authors (first, second and last of 16)
-
Discovery of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of adaptor protein 2-associated kinase 1 for the treatment of pain
Authors (first, second and last of 31)
-
Amide- and bis-amide-linked highly potent and broadly active antifungal agents for the treatment of invasive fungal infections- towards the discovery of pre-clinical development candidate FC12406
Authors (first, second and last of 9)
-
-
-
Structure-based optimization of aminothiadiazole inhibitors of AKT
Authors (first, second and last of 20)
-
Novel potent and highly selective DDR1 inhibitors from integrated lead finding
Authors (first, second and last of 12)
-
-
Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors
Authors (first, second and last of 6)
